Computer-aided retraining of memory and attention in people with multiple sclerosis: a randomized, double-blind controlled trial

https://doi.org/10.1016/j.jns.2004.04.027Get rights and content

Abstract

Context: Cognitive compromise is one of the main contributing factors to activity and participation restrictions in people with multiple sclerosis (MS). Computer-aided programs are used for retraining memory and attention, but data on the efficacy of these interventions are scarce. Objective: To assess the efficacy of computer-aided retraining of memory and attention in people with MS impaired in these abilities. Design and setting: Randomized, double-blind, controlled trial. Participants: Outpatients (n=82) with subjective complaints of poor attention or memory, confirmed by a score <80th percentile in at least two tests of the Brief Repeatable Battery of Neuropsychological Tests (BRBNT). Interventions: Participants were randomized to two computer-assisted retraining interventions: memory and attention (study arm), and visuo-constructional and visuo-motor coordination (control arm). Both groups received 16 training sessions over 8 weeks. Outcome measures: Improvement of 20% or more in at least two BRBNT test scores at 8 weeks compared to baseline (primary end point). Changes in depression and health-related quality of life. Results: An improvement occurred in 45% of study patients vs. 43% of control patients (odds ratio 1.07, 95% confidence interval 0.44–2.64). The study treatment was better than the control treatment only on the word list generation test (p=0.016). Conclusions: This trial does not support the efficacy of specific memory and attention retraining in MS.

Introduction

The reported prevalence of cognitive impairments in people with multiple sclerosis (MS) ranges from 43% to 65% depending on study setting [1], [2]. Cognitive dysfunctions are now considered among the main factors contributing to disease-related activity and participation restrictions [1], [3], [4], and caregiver strain [5]. The functions most consistently affected are controlled attentional processing, speed of information processing, explicit anterograde memory, abstract reasoning, and executive functions [1], [2], [3], [4], [6], [7].

Pharmacological treatments [8], [9], [10], [11], [12], [13], compensatory interventions [14], and computer-aided retraining [15], [16], [17] have been investigated as remedial treatments for cognitive dysfunctions in people with MS. Computer-aided cognitive retraining programs allow unlimited repetitions of a given task and systematic changes in levels of difficulty; they can be self-administered, provide reliable records of patient performance [18], [19] and do not interfere with multi-drug therapies. The available evidence on the usefulness of computer-aided cognitive retraining in MS is however limited.

We designed a randomized, double-blind controlled multicenter trial to assess the efficacy of computer-based retraining of attention and memory in people with MS who complained of mild to moderate impairment of these functions.

Section snippets

Patients

Between January 2001 and May 2002, six Italian centers enrolled 82 people with MS. All met the diagnostic criteria of Poser et al. [20] and complained of poor attention or memory, confirmed by a score below the 80th percentile in at least two components of the Brief Repeatable Battery of Neuropsychological Tests (BRBNT) [21], [22], [23]. Participants were excluded for any one of the following: age less than 18, age over 65 years, Mini-Mental State Examination (MMSE) score <24 [24], [25],

Results

Of the 203 assessed patients, 82 were randomized. Reasons for exclusion were: refused consent (n=45); age>65 years (n=26); co-morbidities (n=15); score below 80th percentile in less than two BRBNT tests (n=22); less than primary education (n=8); exacerbation or steroid therapy (n=5); and MMSE score<24 (n=6).

Of the 82 patients enrolled, 42 were assigned to the study intervention, and 40 to the control intervention. Five randomized participants (6%) never started retraining (2 in the study and 3

Discussion

To our knowledge, this is the first double-blind randomized controlled trial to assess the efficacy of computer-aided retraining of memory and attention in people with MS. We found two previously published studies on this topic. One is a non-randomized trial on 22 outpatients [17]; the other is a randomized controlled pilot study indicating positive effects of computer-assisted memory and attention re-training [16].

We found no indication that the study treatment was superior to the control

Acknowledgements

The authors thank Alessandra Protti MD, and Raffaella Marazzi MD, for their contributions to patient recruitment. We also thank Don Ward for help with the English. The trial was supported by grant PP0798 to Solari from the National MS Society.

References (32)

  • M.F Folstein et al.

    Mini-mental state: a practical method for grading the cognitive state of patients for the clinician

    J. Psychiatr. Res.

    (1975)
  • S.M Rao et al.

    Cognitive dysfunction in multiple sclerosis: I. Frequency, patterns, and prediction

    Neurology

    (1991)
  • O Lyon-Caen et al.

    Cognitive function in recent-onset demyelinating diseases

    Arch. Neurol.

    (1986)
  • M.R Basso et al.

    Screening for cognitive dysfunction in multiple sclerosis

    Arch. Neurol.

    (1996)
  • M Amato et al.

    Cognitive dysfunction in early-onset multiple sclerosis: a reappraisal after 10 years

    Arch. Neurol.

    (2001)
  • S.Y Chipchase et al.

    Factors associated with carer strain in carers of people with multiple sclerosis

    Disabil. Rehabil.

    (2001)
  • W.W Beatty et al.

    Identifying multiple sclerosis patients with mild or global cognitive impairment using the Screening Examination for Cognitive Impairment (SEFCI)

    Neurology

    (1995)
  • W.W Beatty et al.

    Cognitive disturbances in patients with relapsing remitting multiple sclerosis

    Arch. Neurol.

    (1989)
  • A Weinstein et al.

    Neuropsychologic status in multiple sclerosis after treatment with Glatiramer

    Arch. Neurol.

    (1999)
  • J.S Fischer et al.

    Neuropsychological effects of interferon B-1a in relapsing multiple sclerosis

    Ann. Neurol.

    (2000)
  • N.H Pliskin et al.

    Improved delayed visual reproduction test performance in MS patients receiving interferon beta-1b

    Neurology

    (1996)
  • R.C Smits et al.

    The effects of 4-aminopyridine on cognitive function in patients with multiple sclerosis

    Neurology

    (1994)
  • Y Barak et al.

    Effect of interferon-beta-1b on cognitive functions in multiple sclerosis

    Eur. Neurol.

    (2002)
  • Y.M Greene et al.

    A 12-week, open trial of donepezil hydrochloride in patients with multiple sclerosis and associated cognitive impairments

    J. Clin. Psychopharmacol.

    (2000)
  • N.B Lincoln et al.

    Evaluation of cognitive assessment and cognitive intervention for people with multiple sclerosis

    J. Neurol. Neurosurg. Psychiatry

    (2002)
  • A Jønsson et al.

    Effect of neuropsychological treatment in patients with multiple sclerosis

    Acta Neurol. Scand.

    (1993)
  • Cited by (123)

    • Does cognitive training improve attention/working memory in persons with MS? A pilot study using the Cogmed Working Memory Training program

      2021, Multiple Sclerosis and Related Disorders
      Citation Excerpt :

      According to a recent Cochrane review (Rosti-Otajärvi et al., 2014), investigations into cognitive rehabilitation in MS are few and pooled analyses that combined multiple studies yielded non-significant findings across various cognitive domains, including attention/working memory. Despite a number of negative findings (Solari et al., 2004; Tesar et al., 2005), more recent work in MS has showed promise in improving attention/working memory, as well as recruitment of relevant brain networks, particularly when more rigorous criteria are used (Cerasa et al., 2013; Filippi et al., 2012). Emotional and more ecological outcomes (e.g., mood, fatigue, and quality of life) are also receiving more attention in the literature, despite some conflicting findings (Rosti-Otajärvi et al., 2014; Mitolo et al., 2015).

    View all citing articles on Scopus
    1

    Complete list of participants in CRIMS trial: Principal investigators: Alessandra Solari MD1a, Achille Motta MDa, Laura Mendozzi MDb, Eugenio Pucci MDc, Gianluigi Mancardi MDd, Marco Forni MDe, Carlo Pozzilli MDf. Other participants: Elena Barbieri PhDa, Giovanna Borriello MDf, Germana Caldora PhDf, Elisabetta Capello MDd, Domenico Caputo MDb, Elisabetta Cartechini MDc, Manuela Diverio MDe, Paola Gemignani PhDe, Giorgio Giuliani MDc, Loredana La Mantia MDa, Clara Milanese MDa, Marco Paglioritic, Carlo Serrati MDd, Alessandra Tinti MDd, Silvia Volpe PhDd, and Giusi Ferraria. a(National Neurological Institute C. Besta, Milan; bMultiple Sclerosis Unit, Fondazione Don C. Gnocchi, Milan; cNeurology Department, Macerata Hospital, Macerata; dNeurology Clinic, University of Genoa, Genoa; eFondazione Don C. Gnocchi, Marina di Massa; fDepartment of Neurological Sciences, University of Rome, Rome).

    View full text